OHSU

IRB #

IRB00008908

Title

PVAMC / OHSU: Elucidating the Mechanisms that Mediate the Effects of Lipoic Acid in Multiple Sclerosis

Principal Investigator

Sonemany Salinthone

Study Purpose

The purpose of this study is to learn how immune cells collected from blood samples of volunteer subjects respond to the antioxidant, lipoic acid in the lab. This information may help in developing new therapies for the management of symptoms associated with multiple sclerosis.

Medical Condition(s)

Multiple Sclerosis and healthy controls

Eligibility Criteria

Subjects must be veterans at least 18 years of age and willing to provide informed consent. Subjest also must

1) Have a diagnosis of Relapsing Remitting Multiple Sclerosis or be a healthy volunteer
2) NOT have any current substance (except tobacco) or alcohol abuse issues
3) NOT be pregnant or breastfeeding
4) NOT have experienced a MS exacerbation within 30 days of enrollment in the study
5) NOT have any other significant inflammatory diseases or health problems (e.g. active coronary heart disease, diabetes mellitus, or an auto-immune disease)
6) NOT be taking anticoagulant medication such as Heparin, Coumadin, or daily aspirin
7) NOT have taken IV/oral steroids for at least 30 days prior to the blood draw
8) NOT have Anemia
9) NOT have an active infection (as indicated by a fever)
10) NOT have a history of bleeding disorders
11) Weigh >110 lbs
.

Age Range

18 - 100

Healthy Volunteers Needed

Yes

Duration of Participation

This study requires one visit which will last approximately 2 hours. Participants may also consent to future contact by a member of the study team in the event that additional blood samples are needed.

Minors Included

No

Contact

Sarah Egan, MPH
(503) 494-4614

or

Amelia Kerns, BS
(503) 220-8262 ext. 5-6612

Sponsor

The VA is the sponsor of this study (VA Merit Review Award)

Recruitment End

12/31/2017

Compensation Provided

Yes

Compensation

Subjects who are eligible and able to donate blood will be compensated $80 for their time and travel. Subjects who are determined to be ineligible to participate in the study prior to the blood draw will receive a minimum of $25.00 to compensate for their time and cost of travel.


Go Back